Fintech

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

Prnewswire·March 26, 2026 at 12:50 PM

/PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

Wells Fargo virtual assistant aids over 1 billion transactions
PYMNTS
White House crypto czar joins science advisory committee
CoinDesk
David Sacks leaves crypto post for White House
The Block
Lawmakers Question Bank Regulators on Fintech Rules
PYMNTS

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

Wells Fargo virtual assistant aids over 1 billion transactions

White House crypto czar joins science advisory committee

David Sacks leaves crypto post for White House

Lawmakers Question Bank Regulators on Fintech Rules